Open Access Open Access  Restricted Access Subscription Access

Person-centered medicine: currents and crosscurrents in the United States

Sandra Tanenbaum

Abstract


In their editorial introduction to an earlier issue of the International Journal of Person-Centered Medicine, Miles and Mezzich cite positive developments in the United States and United Kingdom. The creation, in the U.S., of the Patient-Centered Outcomes Research Institute (PCORI) is rightly portrayed by these authors as focusing serious attention on the needs of patients for meaningful information about their medical care. PCORI is in some ways--for example, in its apparent commitment to stakeholder engagement and methodological innovation - a departure from earlier public and private efforts to create an evidence base for medical practice. On the other hand, PCORI’s roots and much of the current discourse about its future reflect a residual hold by evidence-based medicine (EBM) on healthcare research and policy-making. First, PCORI was established primarily to promote the conduct of CER, the appetite for which derived from the demand for effectiveness research generally. Second, the patient-centeredness of PCORI is manifest primarily in the conduct of research rather than the process of care. Third, patient-centeredness is commonly taken to refer to patients as a group - as opposed to, say, physicians or researchers as a group -rather than to individual patients. Fourth, it will be difficult and expensive for PCORI to attend to heterogeneity of treatment effects. Fifth and perhaps most important, the creation of PCORI is contemporaneous with other, countervailing, developments in the U.S. healthcare system.


Keywords


2010 Affordable Care Act, Cochrane reviews, health policymaking, patient-centered clinical outcomes, PCORI, person-centered medicine

Full Text:

PDF

References


Miles, A. & Mezzich, J.E. (2011). Person-centered medicine: advancing methods,

promoting implementation. International Journal of Person Centered Medicine 1 (3) 423-428.

Institute of Medicine. (2007). Learning What Works Best: The Nation’s Need for Evidence in Comparative Effectiveness in Health Care. http://www.iom.edu/ebm-effectiveness (accessed Oct 19, 2011).

Iglehart, J.K. (2010). The political fight over comparative effectiveness research. Health Affairs 29 (10) 1757-1760.

Wennberg, J.E. (2010). Tracking Medicine: A Researcher’s Quest to Understand Health Care. New York: Oxford University Press.

Fox, D.M. (2010). The Convergence of Science and Governance: Research, Health Policy, and the American States. Berkeley: University of California Press.

Tunis, S., Stryer, D.B. & Clancy, C. (2003). Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. Journal of the American Medical Association 290 (1) 1624-1632.

Russell, L.B., Gold, M.R., Siegel, J.E., Daniels, N. & Weinstein, M.C. (1996). The role of cost-effectiveness analysis in health and medicine. Journal of the American Medical Association 267 (24) 1172-1177.

Lizza, R. (2009). Money talks: can Peter Orszag keep the President’s goals economically viable? New Yorker 85 (12) 50-59.

White, J. (2011). Prices, volume, and the perverse effects of the variations crusade. Journal of Health Politics, Policy and Law 36 (4) 775-790.

Kaiser Family Foundation. (2009). Explaining Health Reform: What is Comparative Effectiveness Research. http://www.kff.org/healthreform/upload/7946.pdf (accessed Oct 11, 2011).

Wilensky, G.R. (2006). Developing a center for comparative effectiveness information. Health Affairs 25, w572-w585.

Dentzer, S. (2011). The researcher-in-chief at the Patient-Centered Outcomes Research Institute. Health Affairs 30 (12) 2252-2258.

Agency for Healthcare Quality and Research. (2009). Methods to Study the Heterogeneity of Treatment Effects in Comparative Effectiveness Research. http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-reports/?productid=379&pageaction=displayproduct (accessed Jan 19, 2012).

The Third National Comparative Effectiveness Summit, October 12-14, 2011, Mandarin Oriental, Washington, D.C.

Patient-Centeredness in Policy and Practice: A Conference on Evidence, Programs and Implications, November 29-30, Silver Spring, Maryland.

Tanenbaum, S.J. (2009). Pay-for-performance in Medicare: evidentiary irony and the politics of value. Journal of Health Politics, Policy and Law 34 (5) 717-746.

Boyd, C., Darer, J. & Boult, C., Fried, L.B., Boult, L. & Wu, A.W. (2005). Clinical practice guidelines and the quality of care for older patients with multiple comorbid diseases: implications for pay-for-performance. Journal of the American Medical Association 294 (6) 716-724.

Pogach, L.M.A., Tawari, A. & Maney, M., Rajan, M., Miller, D.R. & Aron, D. (2007). Should mitigating comorbidities be considered in assessing healthcare plan performance in achieving optimal glycemic control? American Journal of Managed Care 13, 133-140.

Walter, L.C., Davidowitz, N.P., Heineken, P.A. & Covinsky, K.E. (2004). Pitfalls of converting practice guidelines into quality measures: lessons learned from a VA performance measure. Journal of the American Medical Association 291 (20) 2466-2470.

Fendrick, A.M. & M.E. Chernew. (2006). Value-based insurance design: aligning incentives to bridge the divide between quality improvement and cost containment. http://www.sph.umich.edu/vbidcenter/publications/pdfs/AJMC_06speclFendrick6p.pdf (accessed Jan 19, 2012).

Mello, M.M. & Kachalia. A. (2010). Evaluation of Options for Medical Practice System Reform: A Report to the Medicare Payment Advisory Commission. http://www.medpac.gov/documents/Apr10_MedicalMalpractice_CONTRACTOR.pdf (accessed Jan 19, 2012).




DOI: http://dx.doi.org/10.5750/ejpch.v2i2.691

Refbacks

  • There are currently no refbacks.